US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

24.47

-0.0895-0.36%

Post-market: 24.470.00000.00%16:10 EDT

Volume:1K

Turnover:28.67K

Market Cap:5.63M

PE:- -

High:24.55

Open:24.34

Low:24.34

Close:24.56

52wk High:27.94

52wk Low:22.89

Shares:230.00K

Float Shares:230.00K

Volume Ratio:1.73

T/O Rate:0.51%

Dividend:0.41

Dividend Rate:1.68%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)

Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss

Sector Update: Healthcare

MT Newswires Live

Novo Nordisk (NVO) Receives a Hold from Jefferies

Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.

Viking Therapeutics Says Obesity Drug Showed 'Superior' Results in Study; Shares Jump

MT Newswires Live

Hope Fuels Markets but Reality Could Bite

Viking Therapeutics Reports Strong Obesity Drug Maintenance Data

Viking Therapeutics Shares Rise 38% Premarket After Experimental Drug Maintains Weight Loss in Study

THOMSON REUTERS

Viking Therapeutics' Obesity Drug Shows 22% Weight Loss in Study

Viking Therapeutics reports ‘positive’ results from maintenance study of VK2735

Viking Therapeutics Reports Vk2735 Maintenance Trial Keeps up to 97% of Weight Loss with Every-Other-Week Dosing

Viking Therapeutics, - up to 97% Weight Loss Maintained with Every-Other-Week Dosing for Three Months

THOMSON REUTERS

Viking Therapeutics Announces Positive Topline Results from Maintenance Study of Glp-1/Gip Agonist Vk2735 Demonstrating the Promise of Multiple Maintenance Dosing Regimens

THOMSON REUTERS

Viking Therapeutics, - Maintenance Dosing Shows Gi Adverse Event Rates Similar to Placebo

THOMSON REUTERS

Viking Therapeutics, - Reports 22% Placebo-Adj Weight Loss at Week 33 with Vk2735 17.5 Mg Weekly Dosing

THOMSON REUTERS

Novo Nordisk Investor Day Disappointed

Market Chatter: Novo Nordisk CEO Eyes M&A to Fill Gaps in Drug Portfolio

MT Newswires Live

Novo Stock (NVO): Deutsche Bank Keeps Sell Rating, Says Growth Strategy ‘Underwhelming on Multiple Fronts’

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/THNR/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"THNR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THNR\",,,,,undefined,":{"symbol":"THNR","market":"US","secType":"STK","nameCN":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","latestPrice":24.4699,"timestamp":1791230400000,"preClose":24.5594,"halted":0,"volume":1173,"hourTrading":{"tag":"盘后","latestPrice":24.4699,"preClose":24.4699,"latestTime":"16:10 EDT","volume":7,"amount":170.98949,"timestamp":1791231005379,"change":0,"changeRate":0,"amplitude":0.006126},"delay":0,"changeRate":-0.0036442258361361036,"floatShares":230000,"shares":230000,"eps":0,"marketStatus":"Post-Mkt","change":-0.0895,"latestTime":"10-05 19:10:32 EDT","open":24.34,"high":24.5499,"low":24.34,"amount":28671,"amplitude":0.008547,"askPrice":36.83,"askSize":200,"bidPrice":12.28,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791244800000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":24.5594,"sharesOutstanding":170000,"nav":24.69,"aum":5678700,"dividendRate":0.016841,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":24.4699,"preClose":24.4699,"latestTime":"16:10 EDT","volume":7,"amount":170.98949,"timestamp":1791231005379,"change":0,"changeRate":0,"amplitude":0.006126},"volumeRatio":1.72754},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THNR\",,,,,undefined,":{"symbol":"THNR","floatShares":230000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.72754,"shares":230000,"dividePrice":0.4121,"high":24.5499,"amplitude":0.008547,"preClose":24.5594,"low":24.34,"week52Low":22.89,"pbRate":"--","week52High":27.94,"institutionHeld":0,"latestPrice":24.4699,"committee":-0.333333,"eps":0,"divideRate":0.016841,"volume":1173,"delay":0,"ttmEps":0,"open":24.34,"prevYearClose":25.22,"prevWeekClose":24.5594,"prevMonthClose":25.154,"prevQuarterClose":25.154,"fiveDayClose":25.3347,"twentyDayClose":27.0064,"sixtyDayClose":25.9299},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/THNR\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"THNR","amount":0.41317273,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2025-12-31"},{"date":"2024-12-30","symbol":"THNR","amount":0.219898,"announcedDate":"2024-12-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2024-12-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"THNR\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-30","recordDate":"2024-12-30","paymentDate":"2024-12-31","value":0.219898,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2025-12-31","value":0.41317273,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"THNR\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"THNR\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669472461","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669472461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669472461?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:30","pubTimestamp":1790083809,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lill...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-pyxis-oncology-pyxs-moderna-mrna-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-pyxis-oncology-pyxs-moderna-mrna-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0203201768.USD","LU2213496289.HKD","SG9999014914.USD","LU1551013425.SGD","MEDX","LU2552382058.USD","BK4581","LU2106854487.HKD","IE00BK4W5L77.USD","HRTS","LU0238689110.USD","LU1061106388.HKD","LU0203202063.USD","SG9999018857.SGD","MRNX","LU2271345857.HKD","LU2108987350.USD","LU0882574139.USD","LU0385154629.USD","LU1069344957.HKD","LU1267930730.SGD","IE00BN29S564.USD","LU1232071149.USD","LLYX","OZEM","LU2063271972.USD","LU1127390331.HKD","LU0354030511.USD","LU1064131342.USD","LU2168563687.JPY","LU0640476718.USD","LU2168564149.EUR","LU2237443465.HKD","LU0061475181.USD","LU2265009873.SGD","ELIS","IE00B1XK9C88.USD","LU0471298694.HKD","LU2462591350.SGD","PYXS","PPH","LU2023250330.USD","LU1868836757.USD","IE00BFTCPJ56.SGD","LU2756315664.SGD","LU0417517546.SGD","LU2237438978.USD","SG9999013999.USD","IE0002141913.USD","LU0786609619.USD","LU2112291526.USD","LU1868837136.USD","LU1814569148.SGD","LU2552382132.HKD","LU1712237335.SGD","FTXH","CANC","IE0004445015.USD","LU2168564222.USD","LU2468319806.SGD","BK4548","IE00BJT1NW94.SGD","SGXZ51526630.SGD","LU2491050154.USD","VHT","BK4532","LU0345770993.USD","LU0345770308.USD","SGXZ81514606.USD","LU0689472784.USD","GDOC","IE00B7KXQ091.USD","SG9999015986.USD","LU1548497426.USD","BK4568","LU2111349929.HKD","IE00BFSS7M15.SGD","LU0225283273.USD","LU0823434740.USD","SG9999018865.SGD","LU2324357040.USD","LU2417539215.USD","RXL","IXJ","LU2602419157.SGD","LU1280957306.USD","ELIL","MRNY","LU0466842654.USD","SGXZ31699556.SGD","LLYZ","LU1691799644.USD","LU0708995401.HKD","LU2023250504.SGD","LU0256863811.USD","LU0256863902.USD","CURE","LU0672654240.SGD","LU2746668461.USD","SG9999015945.SGD","LU1093756168.USD","LU2089283258.USD","LU2023251221.USD","IE0005OL40V9.USD","LU0964807845.USD","LU0823434583.USD","LU0432979614.USD","LU1720051108.HKD","LU0058720904.USD","LU0943347566.SGD","BK4533","SG9999014906.USD","IE00BJJMRY28.SGD","LU0354030438.USD","LU1323610961.USD","LU2491050071.SGD","BK4588","LU2028103732.USD","SGXZ99366536.SGD","WDNA","LU0158827948.USD","LU0174119429.USD","LU1291159041.SGD","LU0094547139.USD","IE00BFSS8Q28.SGD","LU0471298777.SGD","LU0109394709.USD","LU1988902786.USD","TRUH","LU0198837287.USD","LU1868837300.USD","LU1366192091.USD","LU2461242641.AUD","IE00B1BXHZ80.USD","LU0210536198.USD","LU2361044865.SGD","SGXZ57979304.SGD","BK4599","LU0133085943.USD","LGHT","FHLC","LU0122379950.USD","LU0114720955.EUR","LU1989771016.USD","IE00B4R5TH58.HKD","LU2360106947.USD","LU2462157665.USD","TMED","LU2237443622.USD","LU2211815571.USD","LU1623119135.USD","LU2089284900.SGD","LU2552382215.SGD","LU2361045086.USD","MHIP","IE00B2B36J28.USD","SG9999015952.SGD","SG9999017495.SGD","SG9999001176.SGD","LU0353189763.USD","LU0096364046.USD","LU0823416689.USD","LU1979441026.SGD","PJP","IE00BWXC8680.SGD","LU0289739699.SGD","LU0316494557.USD","LU2456880835.USD","IE00BKPKM429.USD","SG9999014898.SGD","BK4534","BK4139","LU2896262040.SGD","MEDI","IE0004445239.USD","LU0097036916.USD","IE00B775H168.HKD","LU2471134879.HKD","LU2471134952.CNY","LU0456855351.SGD","LU0266013472.USD","IE0009355771.USD","GNOM","AGNG","LU2237443549.SGD","BK4007","GB00BDT5M118.USD","LU0079474960.USD","LU1917777945.USD","LU0006306889.USD","IE00BJJMRX11.SGD","LU1974910355.USD","LU2237443895.HKD","LU2491049909.HKD","MRNA","LU1868836591.USD","LU2264538146.SGD","IE0001KFT4U8.USD","LLII","LU0323591593.USD","LU2087625088.SGD","LU0882574055.USD","IE00BK4W5M84.HKD","IHE","LU2471134796.USD","LU0106261372.USD","LU0109391861.USD","LU0320765992.SGD","LU0820562030.AUD","LU0889565916.HKD","LU2089984988.USD","BK4501","BK4585","LU0320765059.SGD","ILDR","LU1023059063.AUD","LU2357305700.SGD","LU0158827781.USD","LU2750360641.GBP","LU1629891620.HKD","THNR","LU0683600562.USD","LU2746668974.SGD","SG9999001176.USD","LU1551013342.USD","SG9999015978.USD","LU2236285917.USD","LU2756315318.SGD","LU2168564495.EUR","BK4551","IDNA","IE00BJLML261.HKD","LU0820561909.HKD","BK4516","JDOC","LLY","LU0820561818.USD","LU1145028129.USD","LU1804176565.USD","IYH","IE00BKDWB100.SGD","LU2237443382.USD","LU0234572021.USD","LU2471134523.USD","SG9999014880.SGD","LU0353189680.USD","LU1035775433.USD","LU1057294990.SGD","LU1720051017.SGD","LU1983299246.USD","LU2361044949.HKD","LU2750360997.AUD","LU2237443978.SGD","IE00B4JS1V06.HKD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU1868836914.USD","LU0787776722.HKD","LU2168564065.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142751","title":"Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142751","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142751?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:06","pubTimestamp":1790082402,"startTime":"0","endTime":"0","summary":"FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats upSept 22 (Reuters)-The weight-loss drug market is booming, with biotech firms racing to capture a slice of the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0O6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","LU2168564495.EUR","LU2324357040.USD","LU0417517546.SGD","LU0466842654.USD","IE00BN29S564.USD","IYH","LU2089283258.USD","LU2361044865.SGD","LU0203201768.USD","LU2112291526.USD","LU1988902786.USD","IE0001KFT4U8.USD","LU1979441026.SGD","IXJ","LU2264538146.SGD","GDOC","PJP","PPH","LU0106261372.USD","IE00B4JS1V06.HKD","LU0640476718.USD","LU0471298694.HKD","LU1712237335.SGD","LU1064131342.USD","LU2237443978.SGD","FTXH","LU0889565916.HKD","NVO","VHT","MEDI","SG9999015986.USD","SGXZ99366536.SGD","IE00BKVL7J92.USD","LU0823434740.USD","LU1629891620.HKD","LU1023059063.AUD","LU0122379950.USD","LU1917777945.USD","LU2237438978.USD","LU1069344957.HKD","BK4532","LU2108987350.USD","LU1366192091.USD","LU2360106947.USD","LU2756315664.SGD","LU0353189763.USD","LU1127390331.HKD","LLYX","LU0353189680.USD","LU0114720955.EUR","LU1280957306.USD","LU2023251221.USD","GB00BDT5M118.USD","LU0094547139.USD","IE00B7KXQ091.USD","IE00BWXC8680.SGD","LU1804176565.USD","LU0820561818.USD","BK4581","LU1720051017.SGD","IE00BJJMRY28.SGD","LU2063271972.USD","LU0109391861.USD","FHLC","LU0174119429.USD","LU0385154629.USD","IE00BK4W5M84.HKD","BK4599","LU2237443622.USD","SG9999018865.SGD","LU0198837287.USD","LU2168563687.JPY","SGXZ31699556.SGD","LU0109394709.USD","LU1868837300.USD","LU2028103732.USD","LU2089284900.SGD","SG9999015952.SGD","LU1868836757.USD","BK4585","LU1989771016.USD","IE00B1XK9C88.USD","LU0210536198.USD","LU2089984988.USD","LU2552382215.SGD","IE00BKDWB100.SGD","LU0354030438.USD","IE00BKPKM429.USD","LU2552382058.USD","RXL","LU2491050154.USD","CURE","LU0320765992.SGD","LU2237443895.HKD","SGXZ81514606.USD","LU2750360997.AUD","IE00BJLML261.HKD","LU2462591350.SGD","LU0354030511.USD","IE00BFSS8Q28.SGD","IE0002141913.USD","LU2211815571.USD","BK4007","LU2168564065.EUR","BK4534","NVOH","HRTS","LU2023250504.SGD","LU0964807845.USD","SG9999014906.USD","LU2462157665.USD","LU0158827781.USD","ELIS","LU0097036916.USD","LU1035775433.USD","SG9999014880.SGD","LU2111349929.HKD","LU1551013342.USD","LU1814569148.SGD","LU2552382132.HKD","LU2357305700.SGD","LU2236285917.USD","LU2750360641.GBP","SG9999015978.USD","LU2491050071.SGD","LU2756315318.SGD","MHIP","LU2271345857.HKD","LU2471134952.CNY","LU1057294990.SGD","LU2168564149.EUR","MEDX","LU0158827948.USD","THNR","IE0005OL40V9.USD","LU2602419157.SGD","LU0787776722.HKD","IE00B4R5TH58.HKD","LU0820561909.HKD","LU0256863902.USD","LU0882574055.USD","LU0345770993.USD","LU1093756325.SGD","ILDR","CANC","IE00B775H168.HKD","LU1323610961.USD","LU2361045086.USD","LU1061106388.HKD","LU2361044949.HKD","LU1551013425.SGD","LU1720051108.HKD","LU2168564222.USD","LU0823434583.USD","IE00BJJMRX11.SGD","LU2471134796.USD","BK4533","IE0009355771.USD","LU0316494557.USD","LU0943347566.SGD","LU2237443465.HKD","SG9999014914.USD","LU0432979614.USD","LU1868836914.USD","LU2456880835.USD","SG9999018857.SGD","TMED","LU1983299246.USD","LU1232071149.USD","XLV","LU2237443382.USD","LU0320765059.SGD","BK4516","LU2746668974.SGD","LU2896262040.SGD","LU2491049909.HKD","IHE","LU2746668461.USD","SG9999013999.USD","LU0456855351.SGD","LU1093756168.USD","LU0256863811.USD","IE00B1BXHZ80.USD","LU2106854487.HKD","LU0238689110.USD","LU1868837136.USD","LU1868836591.USD","LU2265009873.SGD","OZEM","LU1548497426.USD","LU0266013472.USD","LLII","IE0004445239.USD","IE00BK4W5L77.USD","BK4588","LU0006306889.USD","LU0820562030.AUD","LU2023250330.USD","LU0345770308.USD","JDOC","LU0203202063.USD","LU2237443549.SGD","IE00BFSS7M15.SGD","IE00B2B36J28.USD","TRUH","NVOX","WDNA","SG9999001176.SGD","LU0689472784.USD","SG9999017495.SGD","LU0683600562.USD","LU0823416689.USD","IE00BZ1G4Q59.USD","LU0133085943.USD","LU2471134523.USD","SG9999015945.SGD","LU0096364046.USD","LU0323591593.USD","LU0471298777.SGD","LU2461242641.AUD","IE00BJT1NW94.SGD","LU1291159041.SGD","SG9999014898.SGD","NVOC","LU2417539215.USD","LU0708995401.HKD","LLYZ","LLY","LU0154236417.USD","LU0079474960.USD","LU2087625088.SGD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU0672654240.SGD","LU1267930730.SGD","SG9999001176.USD","LU2213496289.HKD","LU0061475181.USD","LU0786609619.USD","LU0289739699.SGD","ELIL","LU0882574139.USD","LU2471134879.HKD","LU1691799644.USD","LU1623119135.USD","LU0058720904.USD","LU0225283273.USD","IE0004445015.USD","AGNG","SGXZ51526630.SGD","IE00BJJMRZ35.SGD","LU1145028129.USD","SGXZ57979304.SGD","LU0234572021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174429461","title":"Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1174429461","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174429461?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082018,"startTime":"0","endTime":"0","summary":"Viking Therapeutics (VKTX.US) saw its shares spike nearly 50% in Tuesday's premarket trading after the biotech announced that its experimental obesity drug, VK2735, helped patients maintain most of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MEDI","NVOX","LENZ","BK4599","VKTX","BK4539","XLVI","TRUH","IYH","BK4588","PJP","FXH","THNR","BK4007","NVOH","CURE","OZEM","FHLC","NBDS","BK4585","NVOC","RSPH","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669935142","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2669935142","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669935142?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082001,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF  0.2% lower and the iShares Biotechnology ETF  up 0.6%.Viking Therapeutics  shares were up more than 23% after the company said its subcutaneous VK2735 showed \"superior weight maintenance\" under less frequent dosing regiments compared to placebo over a 12-week period in a clinical study.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4599","BK4588","HCSG","BK4139","IBB","OZEM","BK4137","LABU","BK4581","VKTX","LU0029874061.USD","LU0128526141.USD","XLV","XBI","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142475","title":"Novo Nordisk (NVO) Receives a Hold from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142475","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142475?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:56","pubTimestamp":1790081803,"startTime":"0","endTime":"0","summary":"Jefferies analyst maintained a Hold rating on Novo Nordisk today and set a price target of $42.20. In addition to Jefferies, Novo Nordisk also rece...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-nvo-receives-a-hold-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-nvo-receives-a-hold-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["THNR","BK4585","NVOX","BK4007","BK4532","OZEM","NVO","LU1093756325.SGD","LU1093756168.USD","BK4599","BK4588","IE00BZ1G4Q59.USD","NVOH","LU0154236417.USD","PPH","NVOC","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669445261","title":"Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669445261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669445261?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:22","pubTimestamp":1790079720,"startTime":"0","endTime":"0","summary":"Eli Lilly and Novo Nordisk have been locked in a fierce battle to corner the weight-loss market, and while it is effectively a duopoly now emerging competitors could soon challenge their lead.Seizing ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","LU1988902786.USD","LU2211815571.USD","LU1145028129.USD","SG9999015952.SGD","LU0234572021.USD","RHHBY","LU2462157665.USD","LU2168564495.EUR","LU2468319806.SGD","LU2112291526.USD","LU1035775433.USD","LU0225283273.USD","IE00BWXC8680.SGD","SGXZ99366536.SGD","LU2108987350.USD","LU2750360997.AUD","LU1629891620.HKD","LU1064131342.USD","PJP","CANC","LU2471134879.HKD","VKTX","IE00BJJMRY28.SGD","LU0094547139.USD","LU1232071149.USD","LU2168564065.EUR","LU2462591350.SGD","LU2471134523.USD","LU2089284900.SGD","LU1868836591.USD","SGXZ51526630.SGD","IE00BJT1NW94.SGD","GB00BDT5M118.USD","IE00BJLML261.HKD","LU2271345857.HKD","LU1069344957.HKD","OZEM","IE0009355771.USD","NVOC","LU0354030511.USD","LU0158827781.USD","LU0320765059.SGD","LU2552382132.HKD","LU0820562030.AUD","LU1280957306.USD","LU2756315318.SGD","LU1720051017.SGD","MEDX","LU1551013425.SGD","LU0417517546.SGD","LU1366192091.USD","LLYZ","LU1868836914.USD","LU2746668974.SGD","LU0097036916.USD","LU0006306889.USD","IE00BKVL7J92.USD","JDOC","LU2417539215.USD","LU0158827948.USD","LU0964807845.USD","LU0323591593.USD","BK4532","LU0203201768.USD","ELIS","LU2552382058.USD","LU1093756325.SGD","BK4599","SG9999015978.USD","LU0943347566.SGD","LU2063271972.USD","LU0471298777.SGD","LU2456880835.USD","LU2023250330.USD","LU1551013342.USD","LU2491049909.HKD","LU0471298694.HKD","LU2360106947.USD","LU0882574055.USD","LU0786609619.USD","LU0256863902.USD","LU0823434740.USD","LU1983299246.USD","RXL","LU0708995401.HKD","IE00BN29S564.USD","IE0005OL40V9.USD","LU2602419157.SGD","LU1989771016.USD","LU2237438978.USD","LU0823416689.USD","IE00B2B36J28.USD","LU2756315664.SGD","IE00B4R5TH58.HKD","LU2361045086.USD","IE00BKDWB100.SGD","IYH","LU2106854487.HKD","IE00BKPKM429.USD","SGXZ57979304.SGD","SG9999018857.SGD","LU2023250504.SGD","LU0456855351.SGD","LU0122379950.USD","LU0320765992.SGD","MHIP","BK4534","LU1712237335.SGD","LLII","IE00BJJMRX11.SGD","LU0106261372.USD","LU0289739699.SGD","LU1868837136.USD","LU0096364046.USD","LU1623119135.USD","IE0004445015.USD","LU2265009873.SGD","LU2357305700.SGD","WDNA","SG9999018865.SGD","IHE","LU0198837287.USD","IE00B7KXQ091.USD","NVO","SGXZ81514606.USD","XLV","SG9999001176.SGD","LU2750360641.GBP","TRUH","LU0061475181.USD","LU0109394709.USD","HRTS","SG9999015945.SGD","SG9999017495.SGD","LU0133085943.USD","VHT","LU2264538146.SGD","IE00BZ1G4Q59.USD","LU1291159041.SGD","LU1023059063.AUD","LU0109391861.USD","IE00BK4W5L77.USD","LU0256863811.USD","BK4585","LU2237443465.HKD","AGNG","BK4139","LU0820561818.USD","LU2237443622.USD","LU0154236417.USD","NVOX","LU0889565916.HKD","LU0210536198.USD","LU1691799644.USD","IE00BFSS8Q28.SGD","LU1127390331.HKD","LU1057294990.SGD","SG9999014880.SGD","LU2236285917.USD","PPH","IE00BFSS7M15.SGD","LU1093756168.USD","IE0002141913.USD","LU1979441026.SGD","LU0354030438.USD","LU0683600562.USD","LU2087625088.SGD","ILDR","LU0882574139.USD","LU2491050154.USD","LU2896262040.SGD","LU0114720955.EUR","LU1548497426.USD","LU2237443549.SGD","LU2237443978.SGD","LU2361044949.HKD","LU2237443382.USD","LU1061106388.HKD","LU0820561909.HKD","BK4533","LU2213496289.HKD","SG9999014906.USD","LU2028103732.USD","LLYX","SG9999015986.USD","LU0079474960.USD","LU0432979614.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","LU2111349929.HKD","LU0316494557.USD","LU0238689110.USD","LU0058720904.USD","LU0203202063.USD","THNR","LU2168564222.USD","LU0787776722.HKD","GDOC","IE00BFTCPJ56.SGD","LU1323610961.USD","LU0353189763.USD","LU1917777945.USD","MEDI","SG9999001176.USD","SGXZ31699556.SGD","LU0672654240.SGD","LU0266013472.USD","LU2471134796.USD","LU2552382215.SGD","TMED","BK4516","FTXH","LU2361044865.SGD","SG9999014898.SGD","SG9999014914.USD","LU1868837300.USD","LU2023251221.USD","IE0004445239.USD","NVOH","CURE","IXJ","LU0353189680.USD","IE00B4JS1V06.HKD","LU2237443895.HKD","LU1720051108.HKD","BK4007","LU0174119429.USD","LU2746668461.USD","03165","LU1868836757.USD","ELIL","IE0001KFT4U8.USD","LU0385154629.USD","LU0345770993.USD","LU0689472784.USD","BK4581","LU2491050071.SGD","IE00BK4W5M84.HKD","LU0466842654.USD","LU1804176565.USD","LU1814569148.SGD","LU2168563687.JPY","LU1267930730.SGD","LU2168564149.EUR","BK4588","LU2089283258.USD","LU0640476718.USD","LU0345770308.USD","LU2089984988.USD","LU2471134952.CNY","LU2461242641.AUD","LU2324357040.USD","IE00B775H168.HKD","IE00B1XK9C88.USD","LU0823434583.USD","LLY","LU1974910355.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144843","title":"Viking Therapeutics Says Obesity Drug Showed 'Superior' Results in Study; Shares Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144843","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144843?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:17","pubTimestamp":1790079477,"startTime":"0","endTime":"0","summary":"Viking Therapeutics  said Tuesday its subcutaneous VK2735 showed \"superior weight maintenance\" under less frequent dosing regiments compared to placebo over a 12-week period in a clinical study.Participants randomized to monthly dosing regimens preserved up to 90% of mean weight loss achieved during the induction period, the company said.VK2735 also demonstrated an \"encouraging safety and tolerability profile,\" Viking said.The company said it plans to explore oral dosing regimens in part 2 of the study.Shares of Viking Therapeutics were up more than 36% in premarket trading.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4139","VKTX","OZEM","BK4599","BK4585","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141342","title":"Hope Fuels Markets but Reality Could Bite","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141342","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141342?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:51","pubTimestamp":1790077860,"startTime":"0","endTime":"0","summary":"Good morning and welcome to another hopeful day for markets as Iran lifts Wall Street's spirits.Stocks looked set to continue their positive start to the week as falling oil prices seemed to offset a ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSDD","INTC","LU0528227936.USD","LU1366333091.USD","BK4551","TSYY","LU1732800096.USD","LU0234570918.USD","LU1935043452.HKD","LU0256863902.USD","LU1814569148.SGD","LU1917777945.USD","LU2065169927.USD","SG9999017495.SGD","LU1914381329.SGD","LU0276348264.USD","METU","SMH","LU0648001328.SGD","SINTCmain","TSLG","LU2236285917.USD","LU1803068979.SGD","LU1670711040.USD","BK4535","QQQA","LU0345769631.USD","LU2087625088.SGD","IE00BJJMRX11.SGD","LU0552385451.USD","IE0034235303.USD","BK4574","LU0308772762.SGD","IE0003U64NQ7.SGD","LU2357305700.SGD","LU0109392836.USD","LU2471134796.USD","LU1923623000.USD","SMOG","LU1992135472.HKD","LU1564329461.SGD","LU2473716301.USD","BK4585","LINT","LU2361044949.HKD","STSLAmain","BK4023","BK4532","IE00B3SWFQ91.USD","IE00B4YYXB79.USD","LU1992135399.USD","LU1861220033.SGD","LU1791710400.SGD","TRFK","BETE","LU1232071149.USD","CBOY","TSLO","TSLQ","LU0056508442.USD","LU2357627491.SGD","LU2272731600.USD","FTXL","LU0079474960.USD","IE0034235188.USD","LU0070217475.USD","LU2462591350.SGD","SG9999001077.SGD","LU1868837300.USD","LU2265009873.SGD","PARA","BRRR","LU0788109477.HKD","LU0689472784.USD","IETC","LU1791710582.SGD","AMD","LU0444971666.USD","LU2168564065.EUR","LU2756315318.SGD","LU0964807845.USD","AIS","LU1989772923.USD","SGXZ31699556.SGD","IE00BJTD4V19.USD","BK4605","METD","LU0784385170.HKD","LU2063271972.USD","LU0889565833.HKD","BK4555","LU2290526834.HKD","LU0061475181.USD","LU1852331112.SGD","LU1815333072.USD","IE000MB6IJN5.SGD","LU0210528500.USD","LU0081259029.USD","LU2860962120.EUR","LU0211328371.USD","LU1496350502.SGD","LU2244417387.USD","LU2355687059.USD","SOXX","HODL","IE00BJLML261.HKD","BK4533","LU1551013342.USD","BK4543","IE00B1XK9C88.USD","LU1670628061.USD","METQ","LU2326559502.SGD","IE00B5949003.HKD","LU2931357623.SGD","IE00BZ1G4Q59.USD","NVOC","LU0390134368.USD","LU1868836914.USD","FDRV","LU1718418525.SGD","LU0476273544.USD","CHAT","BTCW","LU0738911758.USD","LU1084165304.USD","LU0082616367.USD","NVOX","TSL","DFII","LU0198837287.USD","LU0210533765.USD","SG9999014914.USD","LU0980610538.SGD","NVO","TSII","IE000BZT7R73.USD","SG9999015945.SGD","LU1720051108.HKD","IE0005OL40V9.USD","LU2764263039.SGD","LU0477156953.USD","LU0466842654.USD","BITX","LU0203347892.USD","TLA","TEK","CBXA","BK4125","BK4507","XNTK","LU1989764664.SGD","FBL","LU0080751232.USD","LU2896262040.SGD","LU1127390331.HKD","WUGI","LU2543165471.USD","LU0225283273.USD","MAXI","LU0985320562.USD","LU0130102774.USD","LU1815336760.USD","LU1989764748.USD","LU2168563687.JPY","LU2322448791.USD","IE000W1ABFV2.USD","TTEQ","LU0912757837.SGD","IE00B1BXHZ80.USD","CBTA","LU0265550946.USD","TEST","SBIT","BK4599","IE0009G5SDU7.USD","BK4614","QBF","BITU","FBY","LU0820561818.USD","TESL","SG9999015986.USD","BK4592","BTF","HK0000914686.HKD","IE00BQXX3F31.USD","LU0353189680.USD","LU2456880835.USD","BTC.USD.CC","DAMD","SG9999015952.SGD","LU0820562030.AUD","GB00B4QBRK32.GBP","SMETAmain","BK4099","LU1674673691.USD","LU0823411888.USD","LU2361045086.USD","IE00BKVL7J92.USD","BK4524","LU2087621335.USD","IE00B4JS1V06.HKD","LU0949170426.SGD","LU1093756325.SGD","LU0068578508.USD","CBTO","LU1839511570.USD","LU0820561909.HKD","LU2463028550.USD","LU0943347566.SGD","IE00BFSS7M15.SGD","LU0433182093.SGD","LU2487616109.SGD","LU2097829019.USD","LU0690374615.EUR","LU0795875169.SGD","SG9999014898.SGD","09766","GAMR","LU1119994496.HKD","LU1303367103.USD","USXF","IE0004445015.USD","LU2168564222.USD","LU1261432733.SGD","SOCL","LU0823434583.USD","BK4579","IE00BKDWB100.SGD","LU1064131342.USD","SGXZ51526630.SGD","LU1267930730.SGD","BITY","WISE","LU0640476718.USD","SG9999004303.SGD","LU0157215616.USD","LU0211331839.USD","LU0784384876.USD","OZEM","LU0708995401.HKD","IBIT","LU2552382132.HKD","ARTY","BK4573","BTCZ","FAI","07766","GXPC","IE0009356076.USD","LU1035775433.USD","LU1880398554.USD","BK4575","IE00BQXX3D17.EUR","LU2089985449.USD","BTCI","LU2272731865.HKD","LU0053666078.USD","LU0787776722.HKD","BK4566","LU0211327993.USD","XDAT","LU0878866978.SGD","IE00B19Z3B42.SGD","ARKB","LU2125154935.USD","IE00BMPRXN33.USD","LU0792757196.USD","IE00BQXX3C00.GBP","LU2065171402.SGD","TSLL","CBOO","LU0011850046.USD","LU0154236417.USD","LU0545039389.USD","IE000F7OJYX1.SGD","GBTC","LU0823434740.USD","LU0444973449.USD","LU1093756168.USD","NVOH","LU0203202063.USD","LU1732799900.SGD","LU2347655156.SGD","IE00BSNM7G36.USD","SG9999014880.SGD","LU0256863811.USD","AMDS","LU0170899867.USD","LU0251131958.USD","LU1670710661.SGD","BK4581","IE00BK4W5L77.USD","LU2242650005.HKD","LIT","BK4108","LU2430703095.HKD","TSLY","FBX","LU0077335932.USD","LU0133085943.USD","LU2552382058.USD","LU2168564495.EUR","LU0348723411.USD","LU2023250330.USD","AMDC","LU1316542783.SGD","LU2458330169.SGD","MNRS","LU2592432038.USD","LU1242518931.SGD","CBXY","LU2403377893.USD","LU1066051498.USD","BPI","AMDD","LU0320765059.SGD","LU2756315664.SGD","BK4141","LU2764262908.HKD","LU1670710588.SGD","BK4516","IE0000B7K699.USD","LU2462157665.USD","LU1935042488.USD","META","BK4548","LU1861558580.USD","LU1548497426.USD","LU0724617625.USD","BK4529","LU0096362180.USD","LU0823421416.USD","LU0265550359.USD","LU0316494557.USD","LU0048584097.USD","BK4515","LU2461242641.AUD","LU2133065610.SGD","LU0208291251.USD","LU2237957811.SGD","LU0784385840.USD","LU1242518857.USD","IE00B7SZLL34.SGD","LU2250418816.HKD","LU1629891620.HKD","LU1116320901.HKD","TSLA","INT","LU1145028129.USD","IE00BWXC8680.SGD","LU2552382215.SGD","LU2602419157.SGD","LU2381873111.SGD","LU0314104364.USD","LU2746668974.SGD","ELOL","LU0345770993.USD","LU0784383803.USD","BK4554","LU1564329032.USD","EZBC","LU2249611893.SGD","IE000WAW04H5.SGD","IE00BJJMRY28.SGD","CHPS","LU1699723380.USD","LU2237957902.USD","LU2404859667.USD","LU2213496289.HKD","LTL","BFAP","IE000YTNTUN2.SGD","LU0274383776.USD","BK4604","CRSH","LU2420271590.USD","LU1564329115.USD","LU2746668461.USD","LU1429558221.USD","SG9999014906.USD","LU1201861249.SGD","BK4007","LU1935042991.SGD","FBYY","LU0354030438.USD","DRIV","LU0052756011.USD","LU2264538146.SGD","LU0061474960.USD","BK4527","CBTJ","LU0251142724.SGD","LU0162691827.USD","LU1066053197.SGD","BCCC","PPH","SGXZ23171101.USD","BITI","LU0742534661.SGD","TSLT","LU2242649171.HKD","BK4512","LU1951200564.SGD","LU2430703251.USD","LU2458330243.SGD","NULC","GB00B4LPDJ14.GBP","BAGY","METV","LU0210536198.USD","LU1003077747.HKD","LU1951198990.SGD","LU1670627923.USD","SGXZ81514606.USD","LU2106854487.HKD","LU2360106780.USD","LU2317271919.USD","IE000KEQY171.SGD","LU1066051811.HKD","LU1697837992.HKD","LU0354030511.USD","LU2054465674.USD","LU2720916845.USD","SOXY","LU1564329628.SGD","LU0128525689.USD","LU2023250504.SGD","LU1861215975.USD","LU1267930813.SGD","LU2505996509.AUD","THNR","WANT","SGXZ99366536.SGD","LU1935043536.SGD","LU0795875086.SGD","LU1059921491.USD","LU0203345920.USD","IE00B19Z3581.USD","04335","LU2247934214.USD","LU1069344957.HKD","AMYY","IE00BN29S564.USD","LU1435385759.SGD","XLC","LU2065170008.USD","IE0004445239.USD","LU0203201768.USD","HK0000914660.USD","BTC","LU1861559042.SGD","LU1066051225.USD","LU1880398471.USD","LU1935043023.USD","WBD","CBXJ","BTCC","IE00B19Z8W00.USD","METW","LU0130517989.USD","LU0786609619.USD","LU0690374961.EUR","AMDL","AIQ","LU1267930490.SGD","AMDG","LU0661504455.SGD","IE000SO60NU8.SGD","BK4598","LU1280957306.USD","AMDU","LU0149725797.USD","LU0321505868.SGD","CBXO","LU2361044865.SGD","LU0072462426.USD","IE00B19Z8X17.USD","LU0345769128.USD","LU0106261372.USD","LU1823568750.SGD","XBTY","CBOJ","LU1046421795.USD","LU1571399168.USD","LU0726765562.USD","VOX","LU1868836591.USD","BITB","INTW","SG9999015978.USD","IE00BFSS8Q28.SGD","LU0070302665.USD","LU2322448957.HKD","LU1804176565.USD","LU0072461881.USD","LU2471134523.USD","LU2108987350.USD","IDRV","LU0048573561.USD","FCOM","LU0310799852.SGD","LU2065171311.SGD","LU2417539215.USD","LU2471134952.CNY","BK4588","LU2430703178.SGD","DEFI","LU2750360997.AUD","LU1116320737.USD","SG9999018865.SGD","LU0979878070.USD","LU2347655073.USD","LU1074936037.SGD","HK0000304805.HKD","LU0096364046.USD","INYY","SG9999002232.USD","LU1974910355.USD","LU0251132253.USD","LU2272731782.SGD","LU2764263203.CNY","TSLP","HK0000304797.USD","IE00B19Z9505.USD","LU0127658192.USD","BAI","BTRN","LU0267386448.USD","LU0823421333.USD","IE00BK4W5M84.HKD","LU2750360641.GBP","LU0174119429.USD","LU0109391861.USD","BK4602","METG","LU1267930227.SGD","PSI","TSLS","LU2471134879.HKD","LU1489326972.SGD","CBTY","LU1989772840.SGD","IE000ITXATA3.USD","LU0859254822.USD","LU2360107168.USD","TESC","LU0353189763.USD","LU0823414478.USD","LU0345770308.USD","TSLW","LU1720051017.SGD","AMUU","LU1366192091.USD","IE00B775H168.HKD","LU0719512351.SGD","LU0097036916.USD","LU2404859741.USD","LU2098885051.SGD","LU2125154778.USD","LEGR","LU0310800965.SGD","SGXZ80539844.SGD","RSPC","LU1642822529.SGD","LU1235294995.USD","LU0187121727.USD","LU1988902786.USD","BK4534","LU0323591593.USD","LU1670711123.USD","LU2148611432.USD","SG9999001424.SGD","LU0553294199.USD","GB00BDT5M118.USD","WATS","09366","LU0061474705.USD","SG9999002224.SGD","BK4550","IE00BMPRXR70.SGD","LU0417517546.SGD","BK4612","CBOA","TSLI","BETH","BFJL","BITO","LU1301847155.USD","TRUC","TSLR","AMDY","LU0215105999.USD","LU0321505439.SGD","07366","LU0882574139.USD","AMDW","LU2505996681.GBP","FBTC","IE00BJTD4N35.SGD","LU2168564149.EUR","TSLZ","LU0320765489.SGD","ILDR","LU0672654240.SGD","LU0949170772.SGD","LU1935042215.USD","IE00B7KXQ091.USD","IE00BMPRXQ63.HKD","LU2360032135.SGD","LU1868836757.USD","YBTC","IE0001KFT4U8.USD","SG9999018857.SGD","BTCL","LU1551013425.SGD","SMHX","LU1674673428.USD","LU0683600562.USD","BK4587","LU1979441026.SGD","OGIG","BK4077","LU0006306889.USD","LU0957791311.USD","LU2023250843.SGD","BTCO","LU1868837136.USD","LU1778281490.HKD","BK4511","LU0234572021.USD","LU1153585028.USD","IE0002270589.USD","SAMD0main","IE000M9KFDE8.USD","LU0957808578.USD","LU0642271901.SGD","LU0889566641.SGD","LU0985489474.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669227149","title":"Viking Therapeutics Reports Strong Obesity Drug Maintenance Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2669227149","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669227149?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:30","pubTimestamp":1790076623,"startTime":"0","endTime":"0","summary":"Viking Therapeutics ( ($VKTX) ) has issued an announcement. On September 22, 2026, Viking Therapeutics reported positive top-line data from a maint...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/viking-therapeutics-reports-strong-obesity-drug-maintenance-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/viking-therapeutics-reports-strong-obesity-drug-maintenance-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["THNR","BK4599","VKTX","BK4585","OZEM","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669149350","title":"Viking Therapeutics Shares Rise 38% Premarket After Experimental Drug Maintains Weight Loss in Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2669149350","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669149350?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:19","pubTimestamp":1790075970,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4599","OZEM","THNR","BK4585","BK4139","VKTX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669146733","title":"Viking Therapeutics' Obesity Drug Shows 22% Weight Loss in Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2669146733","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669146733?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:12","pubTimestamp":1790075521,"startTime":"0","endTime":"0","summary":"Viking Therapeutics' obesity drug shows 22% weight loss in studySept 22 (Reuters)-Viking TherapeuticsVKTX.Osaid on Tuesday its experimental GLP-1 obesity drug helped patients lose 22% of their body weight after 33 weeks of weekly treatment in a maintenance study.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0OG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","BK4585","THNR","BK4599","OZEM","VKTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669493381","title":"Viking Therapeutics reports ‘positive’ results from maintenance study of VK2735","url":"https://stock-news.laohu8.com/highlight/detail?id=2669493381","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669493381?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:10","pubTimestamp":1790075445,"startTime":"0","endTime":"0","summary":"Viking Therapeutics (VKTX) announced positive top-line results from the company’s maintenance study of VK2735, the company’s dual agonist of the gl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/viking-therapeutics-reports-positive-results-from-maintenance-study-of-vk2735-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/viking-therapeutics-reports-positive-results-from-maintenance-study-of-vk2735-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4139","BK4599","OZEM","THNR","VKTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669179146","title":"Viking Therapeutics Reports Vk2735 Maintenance Trial Keeps up to 97% of Weight Loss with Every-Other-Week Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669179146","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669179146?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:05","pubTimestamp":1790075134,"startTime":"0","endTime":"0","summary":"Viking Therapeutics reports VK2735 maintenance trial keeps up to 97% of weight loss with every-other-week dosingViking Therapeutics reported positive topline results from a maintenance study of obesit","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL3vJdWZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","BK4599","BK4139","OZEM","BK4588","BK4585","VKTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669514611","title":"Viking Therapeutics, - up to 97% Weight Loss Maintained with Every-Other-Week Dosing for Three Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2669514611","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669514611?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:05","pubTimestamp":1790075100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUABKSRFB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OZEM","VKTX","BK4139","BK4585","BK4599","THNR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669461111","title":"Viking Therapeutics Announces Positive Topline Results from Maintenance Study of Glp-1/Gip Agonist Vk2735 Demonstrating the Promise of Multiple Maintenance Dosing Regimens","url":"https://stock-news.laohu8.com/highlight/detail?id=2669461111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669461111?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:05","pubTimestamp":1790075100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUABKSRFB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VKTX","THNR","BK4585","BK4139","BK4599","BK4588","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669146116","title":"Viking Therapeutics, - Maintenance Dosing Shows Gi Adverse Event Rates Similar to Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2669146116","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669146116?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:05","pubTimestamp":1790075100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUABKSRFB:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THNR","BK4599","VKTX","BK4585","OZEM","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669112146","title":"Viking Therapeutics, - Reports 22% Placebo-Adj Weight Loss at Week 33 with Vk2735 17.5 Mg Weekly Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669112146","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669112146?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:05","pubTimestamp":1790075100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUABKSRFB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4599","VKTX","BK4588","BK4585","THNR","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669451651","title":"Novo Nordisk Investor Day Disappointed","url":"https://stock-news.laohu8.com/highlight/detail?id=2669451651","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669451651?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:39","pubTimestamp":1790073540,"startTime":"0","endTime":"0","summary":"1038 GMT - Novo Nordisk's capital markets day announcements, including the diversification plan and a vague midterm sales target, disappointed investors, AlphaValue analyst Abhishek Raval writes. \"Against the backdrop of excessive dependency on a single molecule, aggressive and heavy diversification bets, along with impeccable commercial execution, are the need of the hour.\" However, the markets have their reservations, Raval says. The commercial success of oral Wegovy, some promising late-stage assets, and the firepower for acquisitions provide reasons to bet on Novo, which is available at a discount to peers, he adds. AlphaValue rates the Danish drugmaker's stock at buy with a 450 Danish kroner target price. Shares fall 0.2% to 259.40 kroner.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","BK4007","BK4532","LU0154236417.USD","NVOH","IE00BKVL7J92.USD","OZEM","PPH","LU1093756168.USD","BK4585","BK4599","IE00BZ1G4Q59.USD","NVOC","NVOX","BK4588","THNR","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669713148","title":"Market Chatter: Novo Nordisk CEO Eyes M&A to Fill Gaps in Drug Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2669713148","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669713148?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:52","pubTimestamp":1790070723,"startTime":"0","endTime":"0","summary":"Novo Nordisk  Chief Executive Mike Doustdar said the pharmaceutical major is considering acquisitions to bolster its position in the weight-loss drug market, CNBC reported Tuesday, citing an interview.Doustdar said Novo Nordisk will look for weaknesses in its drug lineup and consider acquisitions of treatments that could help close those gaps, CNBC reported.Doustdar said that the market reaction to its new long-term strategy and growth targets showed that the company still has work to do in convincing some investors.Novo Nordisk did not immediately reply to MT Newswires' request for comment.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","LU1093756168.USD","BK4532","BK4588","IE00BZ1G4Q59.USD","NVOX","NVOH","BK4599","OZEM","PPH","NVO","NVOC","BK4007","THNR","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143804","title":"Novo Stock (NVO): Deutsche Bank Keeps Sell Rating, Says Growth Strategy ‘Underwhelming on Multiple Fronts’","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143804","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143804?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:43","pubTimestamp":1790070183,"startTime":"0","endTime":"0","summary":"Novo shares fell 7.96% to $39.80 on Monday after its growth strategy, disclosed at its Capital Markets Day in London, failed to impress investors\n...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-stock-nvo-deutsche-bank-keeps-sell-rating-says-growth-strategy-underwhelming-on-multiple-fronts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-stock-nvo-deutsche-bank-keeps-sell-rating-says-growth-strategy-underwhelming-on-multiple-fronts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOH","LU1093756325.SGD","LU0154236417.USD","NVOX","OZEM","PPH","THNR","BK4599","BK4007","BK4585","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","NVO","NVOC","BK4588","BK4532"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":10,"totalSize":211,"code":"91000000","status":"200"}]}}